Glucagon-Like Peptide-2 Ameliorates Lipid Metabolism in Metabolic Dysfunction‑Associated Steatotic Liver Disease Through the Adiponectin-Adiponectin Receptor-Mediated AMPK/PPARα Pathway
Physiological Research · 10.03.2026 · 113
DOI: 10.33549/physiolres.935711 ↗Kurz gefasst
Fachartikel in der Zeitschrift Physiological Research, online erschienen am 10.03.2026. Verfasst von S-J Zhang und 6 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 58 Literaturangaben.
Abstract (Originalsprache)
The aim of this study was to investigate the mechanisms by which glucagon-like peptide-2 (GLP-2) improves metabolic dysfunction‑associated steatotic liver disease (MASLD) induced by free fatty acids (FFAs) in HepG2 cells, with a focus on the regulation of the adiponectin (ADPN) signaling axis and the downstream AMP-activated protein kinase (AMPK)/peroxisome proliferator-activated receptor α (PPARα) pathway. An MASLD model was established in HepG2 cells by FFA exposure. Following GLP-2 treatment, improvements in lipid metabolism were evaluated using the Cell Counting Kit-8, Oil Red O staining, and biochemical assays. Differential gene expression was examined using RNA sequencing, and potential mechanisms were evaluated through Gene Ontology enrichment and Kyoto Encyclopedia of Genes and Genomes pathway analysis. Western blotting and reverse transcription polymerase chain reaction (RT-PCR) were performed to assess the expression of key molecular components within the signaling pathway. FFA treatment led to significant lipid accumulation in HepG2 cells, whereas GLP-2 reduced intracellular lipid droplet formation (p
Zitieren
APA
Zhang, S., Xu, K., Zhu, F., Chen, J., Zhang, Y., Teng, Y., & Shen, F. (2026). Glucagon-Like Peptide-2 Ameliorates Lipid Metabolism in Metabolic Dysfunction‑Associated Steatotic Liver Disease Through the Adiponectin-Adiponectin Receptor-Mediated AMPK/PPARα Pathway. Physiological Research, 113. https://doi.org/10.33549/physiolres.935711
Vancouver
Zhang S, Xu K, Zhu F, Chen J, Zhang Y, Teng Y, et al. Glucagon-Like Peptide-2 Ameliorates Lipid Metabolism in Metabolic Dysfunction‑Associated Steatotic Liver Disease Through the Adiponectin-Adiponectin Receptor-Mediated AMPK/PPARα Pathway. Physiological Research. 2026:113. doi:10.33549/physiolres.935711
BibTeX
@article{Zhang2026,
author = {Zhang, S-J and Xu, K and Zhu, F and Chen, J-G and Zhang, Y and Teng, Y-Q and Shen, F-F},
title = {Glucagon-Like Peptide-2 Ameliorates Lipid Metabolism in Metabolic Dysfunction‑Associated Steatotic Liver Disease Through the Adiponectin-Adiponectin Receptor-Mediated AMPK/PPARα Pathway},
journal = {Physiological Research},
year = {2026},
pages = {113},
doi = {10.33549/physiolres.935711}
}
EUVIMED